Question 5397 — pharmacy and medications

Summary

Ms. Anaïs Belouassa-Cherifi draws the attention of the Minister to the Minister of Labor, Health, Solidarity and Families, responsible for health and access to care, to the shortages in the supply of medicinal products based on methylphenidate, indicated in the treatment of attention deficit disorder. These shortages, which have persisted for several years, are notably due to an increase in demand and limited production capacities, depending on the laboratories. The National Agency for the Safety of Medicines and Health Products (ANSM) indicates that it is monitoring the situation vigilantly and has put in place certain measures, such as the possibility, on an exceptional and temporary basis, of issuing another medicine based on methylphenidate without a new prescription when the treatment initially prescribed is unavailable. However, these solutions remain insufficient to meet the needs of patients. The distribution of the specialties most suitable for certain treatments, in particular those with prolonged release, remains limited and the prescription of a medicine with a shorter release duration can cause side effects which can prove particularly disabling. The covid-19 crisis has highlighted the country's inability to guarantee the supply of essential medicines. Restoring health sovereignty is a necessity, especially as production gaps make France highly dependent on supply chains that it does not control, often located on the other side of the world. The press kit on the relocation of essential medicines, dating from January 6, 2025, stated that “patients in France must be able to have access to all medicines, both mature medicines but also the most recent medicines”. She therefore asks what measures the Government intends to take to guarantee a stable supply of medicines based on methylphenidate in order to better ensure continuity of care for patients with ADHD and whether the Government's desire to localize the production of medicines in France also concerns those with ADHD. methylphenidate base.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.